Effect of Saccharomyces boulardii CNCM-I 3799 and Bacillus subtilis CU-1 on Acute Watery Diarrhea: A Randomized Double-Blind Placebo- Controlled Study in Indian Children
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: To assess the effect of combination probiotic Saccharomyces boulardii CNCM-I 3799 and Bacillus subtilis CU-1 in outpatient management of acute watery diarrhea in children. Methods: A randomized double-blind placebo-controlled study was conducted in 180 participants aged six months to five years with acute mild to moderate diarrhea. All were enrolled from six centers across India and centrally randomized to receive S. boulardii CNCM-I 3799 and B. subtilis CU-1 or a placebo along with oral rehydration salts and zinc supplementation. Each participant was followed up for three months to assess recurrence of diarrhea. Results: The mean duration of diarrhea in the probiotic and placebo groups were 54.16 hours and 59.48 hours, respectively. The difference in the duration of diarrhea in those administered with probiotic or placebo within 24 hours of diarrhea onset was 25.21 hours. Furthermore, the difference in duration of diarrhea was 13.84 hours (p<0.05) for participants who were administered with probiotics within 48 hours. There were no significant differences in the stool frequencies between the two arms. After three months, 15% in the probiotic group and 18.5% in the placebo group reported episodes of diarrhea. The mean duration of diarrhea was considerably lower in the probiotic group, 31.02 hours versus 48 hours in placebo (p=0.017). Conclusion: S. boulardii CNCM-I 3799 and B. subtilis CU-1 combination was effective in reducing the duration of diarrhea when administered within 48 hours of diarrhea onset. Similarly, it reduced recurrence of diarrhea and its intensity in the subsequent three months.
Abstract
Purpose: To assess the effect of combination probiotic Saccharomyces boulardii CNCM-I 3799 and Bacillus subtilis CU-1 in outpatient management of acute watery diarrhea in children. Methods: A randomized double-blind placebo-controlled study was conducted in 180 participants aged six months to five years with acute mild to moderate diarrhea. All were enrolled from six centers across India and centrally randomized to receive S. boulardii CNCM-I 3799 and B. subtilis CU-1 or a placebo along with oral rehydration salts and zinc supplementation. Each participant was followed up for three months to assess recurrence of diarrhea. Results: The mean duration of diarrhea in the probiotic and placebo groups were 54.16 hours and 59.48 hours, respectively. The difference in the duration of diarrhea in those administered with probiotic or placebo within 24 hours of diarrhea onset was 25.21 hours. Furthermore, the difference in duration of diarrhea was 13.84 hours (p<0.05) for participants who were administered with probiotics within 48 hours. There were no significant differences in the stool frequencies between the two arms. After three months, 15% in the probiotic group and 18.5% in the placebo group reported episodes of diarrhea. The mean duration of diarrhea was considerably lower in the probiotic group, 31.02 hours versus 48 hours in placebo (p=0.017). Conclusion: S. boulardii CNCM-I 3799 and B. subtilis CU-1 combination was effective in reducing the duration of diarrhea when administered within 48 hours of diarrhea onset. Similarly, it reduced recurrence of diarrhea and its intensity in the subsequent three months.
참고문헌 (18)
- Guarino A, "Probiotics for prevention and treatment of diarrhea", J Clin Gastroenterol, 49(Suppl 1), pp.S37~S45 (2015)
- Szajewska H, "Use of probiotics for management of acute gastroenteritis : a position paper by the ESPGHAN Working Group for Probiotics and Prebiotics", J Pediatr Gastroenterol Nutr, 58, pp.531~539 (2014)
- Guarino A, "The management of acute diarrhea in children in developed and developing areas : from evidence base to clinical practice", Expert Opin Pharmacother, 13, pp.17~26 (2012)
- Billoo AG, "Role of a probiotic(Saccharomyces boulardii)in management and prevention of diarrhoea", World J Gastroenterol, 12, pp.4557~4560 (2016)
- Villarruel G, "placebo-controlled study", Acta Paediatr, 96, pp.538~541 (2007)
- Urdaci MC, "Antidiarrheal action of Bacillus subtilis CU1 CNCM I-2745 and Lactobacillus plantarum CNCM I-4547 in mice", Front Microbiol, 9, pp.1537~ (2018)
- Horosheva TV, "Efficacy of Bacillus probiotics in prevention of antibiotic-associated diarrhoea: a randomized, double-blind, placebo-controlled clinical trial", JMM Case Rep, 1, pp.e004036~ (2014)
- Mehta DS, "A study of probiotic Bacillus subtilis HU58 for the management of antibiotic-associated diarrhoea in adults", Indian Pract, 73, pp.22~28 (2020)
- Britton RA, "Probiotics and gastrointestinal infections", Interdiscip Perspect Infect Dis, 2008, pp.290769~ (2008)
- Dinleyici EC, "Time series analysis of the microbiota of children suffering from acute infectious diarrhea and their recovery after treatment", Front Microbiol, 9, pp.1230~ (2018)
- Szajewska H, "Meta-analysis : Saccharomyces boulardii for treating acute diarrhoea in children", Aliment Pharmacol Ther, 25, pp.257~264 (2007)
- Van Niel CW, "Lactobacillus therapy for acute infectious diarrhea in children : a meta-analysis", Pediatrics, 109, pp.678~684 (2002)
- Corrêa NB, "Treatment of acute diarrhea with Saccharomyces boulardii in infants", J Pediatr Gastroenterol Nutr, 53, pp.497~501 (2011)
- Schnadower D, "Lactobacillus rhamnosus GG versus placebo for acute gastroenteritis in children", N Engl J Med, 379, pp.2002~2014 (2018)
- Freedman SB, "Multicenter trial of a combination probiotic for children with gastroenteritis", N Engl J Med, 379, pp.2015~2026 (2018)
- Szajewska H, "Use of probiotics for the management of acute gastroenteritis in children: an update", J Pediatr Gastroenterol Nutr, 71, pp.261~269 (2020)
- Bhatnagar S, "IAP Guidelines 2006 on management of acute diarrhea", Indian Pediatr, 44, pp.380~389 (2007)
- Moré MI, "Saccharomyces boulardii CNCM I-745 improves intestinal enzyme function : a trophic effects review", Clin Med Insights Gastroenterol, 11, pp.1179552217752679~ (2018)